Bookmark

Add to MyYahoo RSS

Impax Laboratories News

News on Impax Laboratories (Ticker: IPXL) continually updated from thousands of sources around the net.

Yesterday | AmericanBankingNews.com

Impax Laboratories Given Consensus Recommendation of "Hold" by Analysts

Shares of Impax Laboratories have been given a consensus recommendation of "Hold" by the sixteen analysts that are presently covering the company, Analyst Ratings Network.com reports .

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Tue Jul 15, 2014

Reuters

Impax Labs get subpoena in price fixing probe

Besides price fixing, the investigation is also to determine if there was an allocation or dividing of customers or territories, the company said in a regulatory filing.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Business Journal

Rising heart drug price pulls Impax into Connecticut AG investigation

The foxglove plant is the source of digoxin, a drug used to control abnormal heart rhythms.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Thu Jul 03, 2014

AmericanBankingNews.com

Impax Laboratories Price Target Raised to $35.00 at WallachBeth Capital

The firm currently has a "buy" rating on the stock. WallachBeth Capital's price objective would indicate a potential upside of 14.68% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Wed Jul 02, 2014

Freshnews

Impax Acquires Two Products from Actavis

Impax Laboratories, Inc. today announced that it has acquired from Actavis plc two generic products for cash consideration pursuant to a Purchase Agreement and a Supply Agreement.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Tue Jul 01, 2014

Freshnews

Impax Laboratories to Announce Results for Second Quarter 2014 on August 6

Impax Laboratories, Inc. announced today that the Company will release its second quarter 2014 financial results on Wednesday, August 6, 2014, prior to the open of the U.S. financial markets.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Mon Jun 30, 2014

Freshnews

Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest

Actavis plc and Forest Laboratories, Inc. today announced that the U.S. Federal Trade Commission has voted to approve Actavis' proposed acquisition of Forest.

Comment?

Related Topix: Biotech, Medicine, Forest Labs, Healthcare Industry, Forest Laboratories, Pharmaceuticals, Startups, Impax Laboratories, Diltiazem (generic), Cardizem, Tiazac, Women's Health, Health

Mon Jun 23, 2014

The Washington Post

Drugmaker Deals Blocking Generics Face New Probes by U.S.

U.S. regulators, armed with a year- old Supreme Court decision, are stepping up probes of pharmaceutical deals that delay the sale of generic drugs, arrangements they view as illegally hurting competition.

Comment?

Related Topix: Biotech, Medicine, Forest Labs, Healthcare Industry, Healthcare Law, Law, Pharmaceuticals, Business News

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••